Framingham, MA, United States of America

Patrick Guirnalda

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Guirnalda in Cancer Therapeutics

Introduction

Patrick Guirnalda, an accomplished inventor located in Framingham, MA, has made significant strides in the field of biomedical research. With three patents to his name, he is particularly noted for his work on therapeutic antibodies aimed at treating cancer.

Latest Patents

Guirnalda's latest patents focus on antibodies that target OX-40, a protein involved in the regulation of immune responses. This invention provides antibodies, or antigen-binding portions thereof, that effectively bind to OX-40. The implications of these antibodies are vast, as they are designed for therapeutic applications in cancer treatment. Furthermore, his patents also detail the cells that produce these antibodies, as well as the polynucleotides encoding both the heavy and light chain variable regions of the antibodies. These innovations represent a promising advancement in cancer therapies, potentially improving patient outcomes through more effective treatment options.

Career Highlights

Patrick Guirnalda is currently affiliated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm dedicated to discovering, developing, and delivering innovative medicines. His work within the company showcases his dedication to advancing medical science, particularly in oncology.

Collaborations

Throughout his career, Guirnalda has worked alongside notable colleagues such as Zhehong Cai and Indrani Chakraborty. Collaborations like these are essential in fostering innovation and developing comprehensive solutions to complex biomedical issues.

Conclusion

Patrick Guirnalda's contributions to cancer therapeutics highlight the critical role inventors play in advancing medical science. His patented work on antibodies against OX-40 not only reflects his innovative spirit but also showcases the impact that dedicated researchers can have on improving healthcare and patient lives. As the field of cancer treatment continues to evolve, Guirnalda's inventions may very well pave the way for new therapeutic strategies that enhance the efficacy of cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…